SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-209859
Filing Date
2023-08-11
Accepted
2023-08-11 08:25:23
Documents
6
Effectiveness Date
2023-08-11

Document Format Files

Seq Description Document Type Size
1 S-8 d417151ds8.htm S-8 43351
2 EX-4.3 d417151dex43.htm EX-4.3 7485
3 EX-5.1 d417151dex51.htm EX-5.1 8902
4 EX-23.2 d417151dex232.htm EX-23.2 2283
5 EX-FILING FEES d417151dexfilingfees.htm EX-FILING FEES 14095
6 GRAPHIC g417151g0810053008235.jpg GRAPHIC 2159
  Complete submission text file 0001193125-23-209859.txt   80205
Mailing Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 617-207-8979
Acrivon Therapeutics, Inc. (Filer) CIK: 0001781174 (see all company filings)

IRS No.: 825125532 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-273908 | Film No.: 231161645
SIC: 2834 Pharmaceutical Preparations